Clinical Trials Directory

Trials / Unknown

UnknownNCT02624297

Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease

Effect of Exercise Training on Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease and Obstructive Sleep Apnea

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that chemoreflex response of muscle sympathetic nerve activity (MSNA) during hypoxia and hypercapnia will be increased in coronary artery disease (CAD) patients and that the presence of obstructive sleep apnea (OSA) will potentiate these responses. And, that the exercise training would decrease the chemoreflex response of MSNA in these patients.

Detailed description

Forty patients with coronary artery disease, with (n=20) and without (n=20) obstructive sleep apnea will be studied. A healthy control, age-paired group (n=10) will be also evaluated. The patients will be submitted to a polysomnography and randomized for clinical follow-up or exercise training for four months. It will evaluated the autonomic function, chemoreflex control of sympathetic activity during hypoxic and hypercapnic maneuvers, endothelial function and inflammatory markers.

Conditions

Interventions

TypeNameDescription
OTHERAerobic exercise trainingThe patients will be submitted to four months of aerobic exercise training, three time a week.

Timeline

Start date
2014-01-01
Primary completion
2017-12-01
Completion
2020-01-01
First posted
2015-12-08
Last updated
2017-05-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02624297. Inclusion in this directory is not an endorsement.